Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Baxter
Deloitte
Dow
McKesson
Express Scripts
Argus Health
Johnson and Johnson
Julphar

Generated: September 20, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY

« Back to Dashboard

Clinical Trials for Children's Cetirizine Hydrochloride Allergy

Trial ID Title Status Sponsor Phase Summary
NCT00253058 Study Of Perennial Allergic Rhinitis In Pediatrics Completed GlaxoSmithKline Phase 3 To verify of cetirizine dry syrup to ketotifen dry syrup in the change of total nasal symptom score (TNSS) over the total treatment period from the score of the baseline assessment period
NCT00257569 Study Of Atopic Dermatitis In Pediatrics Completed GlaxoSmithKline Phase 3 To verify of cetirizine dry syrup to ketotifen dry syrup in the change in the severity of pruritus of the treatment period.
NCT00257582 Study Of Cutaneous Disease Accompanied With Pruritus In Pediatrics Completed GlaxoSmithKline Phase 3 To assess the safety of long-term use of cetirizine dry syrup in children with various type of cutaneous disease accompanied on pruritus.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Children's Cetirizine Hydrochloride Allergy

Condition Name

Condition Name for Children's Cetirizine Hydrochloride Allergy
Intervention Trials
Allergic Rhinitis 4
Rhinitis, Allergic, Perennial 3
Pruritus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Children's Cetirizine Hydrochloride Allergy
Intervention Trials
Rhinitis, Allergic 9
Rhinitis 9
Rhinitis, Allergic, Perennial 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Children's Cetirizine Hydrochloride Allergy

Trials by Country

Trials by Country for Children's Cetirizine Hydrochloride Allergy
Location Trials
Italy 2
Japan 1
Poland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Children's Cetirizine Hydrochloride Allergy

Clinical Trial Phase

Clinical Trial Phase for Children's Cetirizine Hydrochloride Allergy
Clinical Trial Phase Trials
Phase 4 3
Phase 3 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Children's Cetirizine Hydrochloride Allergy
Clinical Trial Phase Trials
Completed 9
Unknown status 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Children's Cetirizine Hydrochloride Allergy

Sponsor Name

Sponsor Name for Children's Cetirizine Hydrochloride Allergy
Sponsor Trials
GlaxoSmithKline 5
Merck Sharp & Dohme Corp. 2
Pfizer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Children's Cetirizine Hydrochloride Allergy
Sponsor Trials
Industry 10
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Express Scripts
Deloitte
UBS
Julphar
Healthtrust
Baxter
Moodys
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.